DOAC-Remove™ 50
Ref. No. 5D-82410B

DOAC-Remove™ 50 tablets are intended to be used for removal of Direct Oral Anticoagulant (DOAC) compounds from human citrated plasma samples, including dabigatran, rivaroxaban, apixaban and edoxaban. Also removes argatroban. DOAC-Remove™ has no significant effect on clotting factors. Currently not for sale in US.

Size 50 tablets
Register to see prices
SKU: 5D-82410B Category:

Description

Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as APTT, TT, single factors, lupus AC, and APC-R.

DOAC-Remove™ is a CE marked product made to the exact specifications of 5-Diagnostics
For In Vitro Use Only.

 

Additional information

Size

50 tablets

You may also like…